The healthcare industry has recommended several reforms to reduce costs of key medicines.
The reforms aim to enhance accessibility, as well as promote innovation.
The proposals are being considered by the European Commission and the European Parliament.
The European Parliament is also considering reforms to the European Medicines Agency's rules on the use of drugs in the EU.
The Commission is considering a proposal that would see the EU take over responsibility for the production of some of the world's most expensive drugs.
A customized collection of grant news from foundations and the federal government from around the Web.
Glasgow Caledonian University (GCU) has launched a series of noteworthy research projects to learn if social enterprises can help Scotland lose its “sick man of Europe” label and boost the nation’s overall health.